查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1565662

基于唾液的筛检市场，按类型、应用、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Saliva-based Screening Market, By Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 322 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023 年基于唾液的筛检市场规模为 3.509 亿美元，2024 年至 2032 年复合年增长率为 8.20%。

唾液筛检市场-市场动态

对方便、准确的诊断解决方案的需求不断增长，推动了基于唾液的筛检市场的成长

对方便、准确的诊断解决方案不断增长的需求极大地推动了基于唾液的筛检市场的成长。例如，美国食品药物管理局(FDA) 在疫情期间批准了多项基于唾液的COVID-19 检测，到2021 年底将授权超过800 万项检测用于紧急使用。 ) 强调与鼻拭子相比，这些测试的优点是易于使用并减少不适。此外，使用唾液进行基因检测的进步（例如 23andMe 等公司开发的检测）正在提高诊断准确性和消费者可近性。对非侵入性、用户友好的测试方法的推动符合更广泛的医疗保健趋势，强调患者的舒适度和易用性，从而推动了市场的扩张。将基于唾液的测试纳入日常健康监测和预防保健进一步支持了这种不断增长的需求。

基于唾液的筛检市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 8.20% 左右的复合年增长率成长

根据类型细分，聚合酶炼式反应 (PCR) 预计将在 2023 年显示最大的市场份额

从应用细分来看，2023年传染病检测为主导类型

按地区划分，北美是 2023 年的主要收入来源

基于唾液的筛检市场細項分析：

全球唾液筛检市场根据类型、应用、最终用户和地区进行细分。

市场依类型分为四大类：酵素连结免疫吸附测定（ELISA）、聚合酶链反应（PCR）、侧流测定（LFA）和生物感测器。聚合酶炼式反应 (PCR) 因其高灵敏度和准确性而引领市场。接下来是酵素连结免疫吸附测定 (ELISA)，可在各种应用中提供可靠的检测。侧向层析分析 (LFA) 因其简单性而广受欢迎，而生物感测器则不断涌现，具有创新功能。

市场根据应用分为四大类：传染病检测、药物和酒精检测、基因检测和荷尔蒙检测。由于对非侵入性检测方法的高需求，传染病检测是主要应用。在个人化医疗进步的推动下，基因检测随之而来。药物和酒精测试很重要，而荷尔蒙测试虽然很重要，但在基于唾液的诊断中不太普遍。

唾液筛检市场-地理洞察

基于唾液的筛检市场表现出显着的地区差异，其中北美由于先进的医疗基础设施和高采用率而处于领先地位。在美国，FDA 在大流行期间授权基于唾液的 COVID-19 检测促进了广泛使用，仅在 2022 年就进行了超过 600 万次检测。欧洲紧随其后，英国和德国等国家将基于唾液的诊断纳入其医疗保健系统。例如，英国国家医疗服务体系 (NHS) 已针对各种健康状况纳入唾液检测，提高了诊断的可近性。由于对医疗保健技术的投资增加以及对非侵入性检测方法的认识不断提高，亚太地区，特别是日本和韩国，正在经历快速增长。在日本，卫生部支持开发和使用基于唾液的诊断方法来管理慢性病。拉丁美洲、中东和非洲是新兴市场，受到不断扩大的医疗基础设施和不断增加的促进非侵入性诊断解决方案的公共卫生倡议的推动。

基于唾液的筛检市场-竞争格局：

OraSure Technologies 等领先公司透过合作伙伴关係扩大了产品范围，例如与比尔及梅琳达盖兹基金会合作，以提高低收入国家基于唾液的爱滋病毒检测的可及性。 PerkinElmer 在基于唾液的 COVID-19 诊断创新方面一直处于领先地位，收购了诊断公司 BioLegend 以增强其能力。此外，Spectrum Solutions 与伊利诺大学合作开发基于唾液的 COVID-19 检测，几个月内处理了超过 100 万次检测。 23andMe 继续引领以唾液为基础的基因检测，透过与製药公司合作进行研究，扩大其影响范围。这些公司透过收购、合作和产品创新推动市场成长，提高唾液诊断的可及性和效率。

最新进展：

2024 年 8 月，Lord's Mark Microbiotech 计画推出基于唾液的器官年龄测试，利用表观遗传学评估器官的生物学年龄。它的价格在 15,000 至 20,000 卢比之间，旨在提供个人化的健康见解并促进积极的医疗干预。

2021年7月，Bio Farma和Nusantics推出了使用漱口法的有限Bio Saliva COVID-19 PCR检测测试。这种创新方法旨在简化测试并提高可近性，从而加强管理和控制 COVID-19 传播的努力。

目录

第一章：基于唾液的筛检市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按类型分類的基于唾液的筛检市场片段
    • 基于唾液的筛检市场片段（按应用）
    • 最终用户基于唾液的筛检市场片段
    • 按国家/地区分類的基于唾液的筛检市场片段
    • 按地区分類的基于唾液的筛检市场片段
  • 竞争洞察

第 3 章：基于唾液的筛检主要市场趋势

  • 基于唾液的筛检市场驱动因素
    • 市场驱动因素的影响分析
  • 基于唾液的筛检市场限制
    • 市场限制影响分析
  • 基于唾液的筛检市场机会
  • 唾液筛检市场未来趋势

第 4 章：基于唾液的筛检产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：基于唾液的筛检市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：基于唾液的筛检市场格局

  • 2023 年基于唾液的筛检市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：基于唾液的筛检市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 酵素连结免疫吸附测定法 (ELISA)
    • 聚合酶炼式反应 (PCR)
    • 侧流层析 (LFA)
    • 生物感测器

第 8 章：基于唾液的筛检市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 传染病检测
    • 药物和酒精测试
    • 基因检测
    • 荷尔蒙测试

第 9 章：基于唾液的筛检市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 诊断实验室
    • 家庭护理设置
    • 研究所

第 10 章：基于唾液的筛检市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美唾液筛检主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲唾液筛检主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区唾液筛检主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲唾液筛检主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 唾液筛检中东和非洲主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 唾液筛检产业

  • 竞争仪表板
  • 公司简介
    • Abbott Laboratories
    • ALPCO Diagnostics
    • Bio-Rad Laboratories, Inc.
    • Diabetomics, Inc.
    • DNA Genotek Inc. (a subsidiary of OraSure)
    • F. Hoffmann-La Roche AG
    • Mawi DNA Technologies LLC
    • Miraculins Inc.
    • Oasis Diagnostics Corporation
    • Oranoxis, Inc.
    • OraSure Technologies, Inc.
    • PerkinElmer, Inc.
    • Quest Diagnostics Incorporated
    • Salimetrics, LLC
    • Thermo Fisher Scientific Inc.
    • ZRT Laboratory LLC
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV3858

REPORT HIGHLIGHT

Saliva-based Screening Market size was valued at USD 350.90 Million in 2023, expanding at a CAGR of 8.20% from 2024 to 2032.

The Saliva-Based Screening Market focuses on diagnostic tests that use saliva samples for detecting various conditions, offering a non-invasive alternative to traditional methods. The market is expanding due to increasing demand for convenient and accurate diagnostic solutions. For example, during the COVID-19 pandemic, saliva-based tests gained prominence as they provided a less invasive method for large-scale testing, with over 10 million tests conducted globally in 2021. However, the market faces challenges such as variability in saliva sample quality and limited standardization across tests. Opportunities are emerging from advancements in saliva-based genetic testing and the development of new diagnostic assays for chronic diseases and infections. Additionally, the growing trend toward personalized medicine and increased funding for non-invasive diagnostic research are expected to drive further growth in this sector. The rise in preventive healthcare and self-testing also contributes to the expanding adoption of saliva-based screening solutions.

Saliva-based Screening Market- Market Dynamics

Increasing Demand for Convenient and Accurate Diagnostic Solutions Fuels Growth in Saliva-Based Screening Market

The increasing demand for convenient and accurate diagnostic solutions is significantly fueling growth in the Saliva-Based Screening Market. For instance, the U.S. Food and Drug Administration (FDA) approved several saliva-based COVID-19 tests during the pandemic, with over 8 million tests authorized for emergency use by late 2021. The Centers for Disease Control and Prevention (CDC) highlighted the benefits of these tests for their ease of use and reduced discomfort compared to nasal swabs. Furthermore, advancements in genetic testing using saliva, such as those developed by companies like 23andMe, are enhancing diagnostic accuracy and consumer accessibility. The push towards non-invasive, user-friendly testing methods aligns with broader healthcare trends emphasizing patient comfort and ease of use, driving the market's expansion. The integration of saliva-based tests into routine health monitoring and preventive care further supports this growing demand.

Saliva-based Screening Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.20% over the forecast period (2024-2032)

Based on Type segmentation, Polymerase Chain Reaction (PCR) was predicted to show maximum market share in the year 2023

Based on application segmentation, Infectious Disease Detection was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Saliva-based Screening Market- Segmentation Analysis:

The Global Saliva-based Screening Market is segmented on the basis of Type, Application, End-User, and Region.

The market is divided into four categories based on Type: Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR), Lateral Flow Assay (LFA), and Biosensors. Polymerase Chain Reaction (PCR) leads the market due to its high sensitivity and accuracy. Enzyme-linked immunosorbent Assay (ELISA) follows, offering reliable detection in various applications. Lateral Flow Assay (LFA) is popular for its simplicity, while biosensors are emerging with innovative capabilities.

The market is divided into four categories based on application: Infectious Disease Detection, Drug and Alcohol Testing, Genetic Testing, and Hormonal Testing. Infectious disease detection is the leading application due to the high demand for non-invasive testing methods. Genetic testing follows, driven by advancements in personalized medicine. Drug and alcohol testing is significant, while hormonal testing, though important, is less prevalent in saliva-based diagnostics.

Saliva-based Screening Market- Geographical Insights

The Saliva-Based Screening Market exhibits notable regional differences, with North America leading due to advanced healthcare infrastructure and high adoption rates. In the U.S., the FDA's authorization of saliva-based COVID-19 tests during the pandemic facilitated widespread use, with over 6 million tests conducted in 2022 alone. Europe follows, with countries like the UK and Germany integrating saliva-based diagnostics into their healthcare systems. For example, the UK's National Health Service (NHS) has incorporated saliva tests for various health conditions, enhancing diagnostic accessibility. The Asia-Pacific region, particularly Japan and South Korea, is experiencing rapid growth due to increased investments in healthcare technology and rising awareness of non-invasive testing methods. In Japan, the Ministry of Health has supported the development and use of saliva-based diagnostics for chronic disease management. Latin America and the Middle East & Africa are emerging markets, driven by expanding healthcare infrastructure and increasing public health initiatives promoting non-invasive diagnostic solutions.

Saliva-based Screening Market- Competitive Landscape:

Leading companies like OraSure Technologies have expanded their product offerings through partnerships, such as their collaboration with the Bill & Melinda Gates Foundation to enhance the accessibility of saliva-based HIV testing in low-income countries. PerkinElmer has been at the forefront with innovations in saliva-based diagnostics for COVID-19, acquiring diagnostic company BioLegend to boost its capabilities. Additionally, Spectrum Solutions partnered with the University of Illinois to develop saliva-based testing for COVID-19, resulting in over 1 million tests being processed within months. 23andMe continues to pioneer saliva-based genetic testing, expanding its reach through collaborations with pharmaceutical companies for research purposes. These companies are driving market growth through acquisitions, partnerships, and product innovation, enhancing the accessibility and efficiency of saliva-based diagnostics.

Recent Developments:

In August 2024, Lord's Mark Microbiotech plans to launch a saliva-based organ age test, assessing the biological age of organs using epigenetics. Priced between Rs 15,000 and 20,000, it aims to provide personalized health insights and promote proactive healthcare interventions.

In July 2021, Bio Farma and Nusantics launched a limited Bio Saliva COVID-19 PCR detection test using a gargle method. This innovative approach aims to simplify testing and increase accessibility, enhancing efforts to manage and control the spread of COVID-19.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SALIVA-BASED SCREENING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • ALPCO Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Diabetomics, Inc.
  • DNA Genotek Inc. (a subsidiary of OraSure)
  • F. Hoffmann-La Roche AG
  • Mawi DNA Technologies LLC
  • Miraculins Inc.
  • Oasis Diagnostics Corporation
  • Oranoxis, Inc.
  • OraSure Technologies, Inc.
  • PerkinElmer, Inc.
  • Quest Diagnostics Incorporated
  • Salimetrics, LLC
  • Thermo Fisher Scientific Inc.
  • ZRT Laboratory LLC
  • Others

GLOBAL SALIVA-BASED SCREENING MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Polymerase Chain Reaction (PCR)
  • Lateral Flow Assay (LFA)
  • Biosensors

GLOBAL SALIVA-BASED SCREENING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Infectious Disease Detection
  • Drug and Alcohol Testing
  • Genetic Testing
  • Hormonal Testing

GLOBAL SALIVA-BASED SCREENING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Homecare Settings
  • Research Institutes

GLOBAL SALIVA-BASED SCREENING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Saliva-based Screening Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Saliva-based Screening Market Snippet by Type
    • 2.1.2. Saliva-based Screening Market Snippet by Application
    • 2.1.3. Saliva-based Screening Market Snippet by End-User
    • 2.1.4. Saliva-based Screening Market Snippet by Country
    • 2.1.5. Saliva-based Screening Market Snippet by Region
  • 2.2. Competitive Insights

3. Saliva-based Screening Key Market Trends

  • 3.1. Saliva-based Screening Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Saliva-based Screening Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Saliva-based Screening Market Opportunities
  • 3.4. Saliva-based Screening Market Future Trends

4. Saliva-based Screening Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Saliva-based Screening Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Saliva-based Screening Market Landscape

  • 6.1. Saliva-based Screening Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Saliva-based Screening Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Enzyme-Linked Immunosorbent Assay (ELISA)
    • 7.1.3. Polymerase Chain Reaction (PCR)
    • 7.1.4. Lateral Flow Assay (LFA)
    • 7.1.5. Biosensors

8. Saliva-based Screening Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Infectious Disease Detection
    • 8.1.3. Drug and Alcohol Testing
    • 8.1.4. Genetic Testing
    • 8.1.5. Hormonal Testing

9. Saliva-based Screening Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Diagnostic Laboratories
    • 9.1.4. Homecare Settings
    • 9.1.5. Research Institutes

10. Saliva-based Screening Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Saliva-based Screening Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Saliva-based Screening Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Saliva-based Screening Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Saliva-based Screening Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Saliva-based Screening Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Saliva-based Screening Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Abbott Laboratories
    • 11.2.2. ALPCO Diagnostics
    • 11.2.3. Bio-Rad Laboratories, Inc.
    • 11.2.4. Diabetomics, Inc.
    • 11.2.5. DNA Genotek Inc. (a subsidiary of OraSure)
    • 11.2.6. F. Hoffmann-La Roche AG
    • 11.2.7. Mawi DNA Technologies LLC
    • 11.2.8. Miraculins Inc.
    • 11.2.9. Oasis Diagnostics Corporation
    • 11.2.10. Oranoxis, Inc.
    • 11.2.11. OraSure Technologies, Inc.
    • 11.2.12. PerkinElmer, Inc.
    • 11.2.13. Quest Diagnostics Incorporated
    • 11.2.14. Salimetrics, LLC
    • 11.2.15. Thermo Fisher Scientific Inc.
    • 11.2.16. ZRT Laboratory LLC
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us